Search results
Author(s):
Marianna Fontana
,
Added:
1 year ago
In this Meet the Experts session, from e-SPACE Heart Failure 2024, Prof Marianna Fontana and Prof Arnt Kristen explore the management of transthyretin amyloid cardiomyopathy (ATTRCM) and discuss strategies for optimising patient care pathways.
View more
Added:
7 months ago
Source:
Radcliffe Cardiology
Results from the Phase III VICTOR trial, presented at the European Society of Cardiology (ESC) Congress 2025 and published in The Lancet, show that vericiguat did not meet its primary endpoint in patients with chronic, stable heart failure with reduced ejection fraction (HFrEF).¹˒²Vericiguat is an oral, once-daily stimulator of soluble guanylate cyclase (sGC), an enzyme in the nitric oxide…
View more
Author(s):
Dan Lenihan, Flora Huang, Jose Alvarez-Cardona
Start date:
Oct 02, 2025
Join Dr Dan Lenihan (Saint Francis Healthcare System, US), Dr Flora Huang (North York General Hospital, CA) and Dr Jose Álvarez Cardona (New York University School of Medicine, US) for this month's Journal Club where they will discuss phenotypes of myocardial dysfunction on serial echocardiography and CMR in women with early-stage breast cancer.This expert-led webinar explores mechanisms of…
View more
Erwan Donal
Research Area(s) / Expertise:
Job title: Cardiologist
Author
NVM Cardiology Meeting Reflections: ACC 26 Preview
Video Series
Author(s):
Biykem Bozkurt, Pardeep Jhund, Muthiah Vaduganathan
Start date:
Sep 11, 2024
Join us for an unparalleled educational journey dedicated to tackling the complexities of managing HFpEF and HFmrEF patients. This CME-accredited live roundtable is chaired by Dr Biykem Bozkurt (Baylor College of Medicine, US) and features insights from renowned experts Prof Pardeep Jhund (University of Glasgow, UK) and Dr Muthiah Vaduganathan (Brigham and Women’s Hospital and Harvard Medical…
View more
Author(s):
Milind Y Desai
Added:
1 year ago
AHA Conference 2024 - 22 month data from the risk evaluation and mitigation strategy (REMS) program for mavacamten (Camzyos; Bristol-Myers Squibb Company) in hypertrophic cardiomyopathy (HCM) patients.Dr Milind Desai (Cleveland Clinic, Ohio, US) joins us onsite at AHA Conference to discuss the findings from the REMS program for mavacamten.The REMS program investigated the safety and efficacy of…
View more
Author(s):
Anjali T Owens
Added:
6 months ago
Navigate the rapidly evolving treatment landscape for hypertrophic cardiomyopathy with Dr Anjali Tiku Owens, a renowned expert in inherited cardiovascular diseases and advanced heart failure.This comprehensive presentation, part of the Cardiomyopathies track of Women As One's CLIMB® 2025 Skills Training Program, explores both established and emerging therapeutic approaches for obstructive and non…
View more
Author(s):
Joe Carver, Osnat Itzhaki Ben Zadok, Jose Alvarez-Cardona
Start date:
Nov 06, 2025
Join Dr Joe Carver (University of Pennsylvania, US), Dr Osnat Itzhaki Ben Zadok (Rabin Medical Center, IL) and Dr Jose Álvarez Cardona (New York University School of Medicine, US) for this month's Journal Club where they will discuss pathways to cardiac recovery after anthracycline-induced cardiomyopathy.The partnership combines Radcliffe’s rapidly growing global community and expertise in…
View more
Author(s):
Victoria Delgado
,
Clara Saldarriaga
Added:
10 months ago
In this expert clinical discussion, join Prof Victoria Delgado as she discusses her manuscript on multimodality imaging approaches in hypertrophic cardiomyopathy (HCM). Dr Clara Saldarriaga, Guest Editor of the HCM special focus collection, facilitates this in-depth conversation exploring how different imaging techniques enhance diagnosis, phenotyping, and risk stratification in HCM patients.The…
View more